Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acurx Pharmaceuticals Inc (NQ: ACXP )

1.350 +0.050 (+3.85%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 183,151
Open 1.350
Bid (Size) 1.340 (3)
Ask (Size) 1.370 (1)
Prev. Close 1.300
Today's Range 1.300 - 1.430
52wk Range 1.180 - 5.280
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bitcoin Hits New All-Time High Above $98,000 As Spot ETFs Crack $100 Billion Net Asset Value Milestone
As Bitcoin (CRYPTO: BTC) hit a new all-time high of $98,310 on Thursday morning during European trading hours, he total net asset value of U.S. Bitcoin spot exchange-traded funds (ETFs) has exceeded... 
Via Benzinga
Topics ETFs
Earnings Scheduled For November 13, 2024
Via Benzinga

Performance

YTD
-66.25%
-66.25%
1 Month
-26.63%
-26.63%
3 Month
-38.64%
-38.64%
6 Month
-46.22%
-46.22%
1 Year
-64.29%
-64.29%

More News

Read More
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
Via ACCESSWIRE
New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
Via ACCESSWIRE
Bloomberg’s “New to The Street” Segment by PetVivo Inc. (OTCQB: PETV) Stocks to Watch This Week inside….
Via AB Newswire
Topics Electric Vehicles
Exposures Electric Vehicles
New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST
Via ACCESSWIRE
A Preview Of Acurx Pharmaceuticals's Earnings
Via Benzinga
New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
Via ACCESSWIRE
New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST
Via ACCESSWIRE
New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
Via ACCESSWIRE
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q2 2024
Via InvestorPlace
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q1 2024
Via InvestorPlace
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 18, 2024
Via Benzinga
New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV
Via AB Newswire
Acurx Pharmaceuticals’ Phase 2b Results For Ibezapolstat Bests Standard Of Care Vancomycin To Treat C. Difficile ($ACXP)
Via AB Newswire
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?
Via Benzinga
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.